In the crystal structure of the title compound (as its hemihydrate, C9H12N6O2 . 0.5H(2)O), a potential intermediate for the synthesis of peptidic nucleic acids containing 2,6-diaminopurine, the asymmetric unit contains two molecules, one ordered and the other with twofold positional disorder about a pivot point near the 6-amino group, together with one water molecule. The side chain emerges at N9 with C8-N9-C10-C11 torsion angles of 93.0(2) and 50.8(6)/-97.0(6)degrees, respectively.
SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF
申请人:RAYAN ANWAR
公开号:US20100284959A1
公开(公告)日:2010-11-11
The present invention provides specific double-stranded DNA/RNA binding compounds having a polymeric structure, which are in fact, triplex forming molecules capable of binding tightly and specifically to predetermined sequences in the major groove of double stranded nucleic acid molecules; as well as pharmaceutical compositions comprising thereof. The triplex forming molecules and the pharmaceutical compositions of the invention can be used for various therapeutic applications such as site-specific modulation of gene expression and targeting of DNA or RNA damage, as well as for diagnostic applications in vitro.
[EN] SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS DE LIAISON À L'ADN/ARN DOUBLE BRIN SPÉCIFIQUES DE CERTAINES SÉQUENCES ET LEURS UTILISATIONS
申请人:GENEARREST LTD
公开号:WO2012011114A2
公开(公告)日:2012-01-26
The present invention provides specific double-stranded DNA/RNA binding compounds having a polymeric structure, which are in fact, triplex forming molecules capable of binding tightly and specifically to predetermined sequences in the major groove of double stranded nucleic acid molecules; as well as pharmaceutical compositions comprising thereof. The triplex forming molecules and the pharmaceutical compositions of the invention can be used for various therapeutic applications such as site-specific modulation of gene expression, targeting of DNA or RNA damage, and gene knockout, as well as for diagnostic applications in vitro.
2,6-Diamino-9-(carboxymethyl)purine Ethyl Ester
作者:G. Sood、C. H. Schwalbe、W. Fraser
DOI:10.1107/s0108270197006598
日期:1997.11.15
In the crystal structure of the title compound (as its hemihydrate, C9H12N6O2 . 0.5H(2)O), a potential intermediate for the synthesis of peptidic nucleic acids containing 2,6-diaminopurine, the asymmetric unit contains two molecules, one ordered and the other with twofold positional disorder about a pivot point near the 6-amino group, together with one water molecule. The side chain emerges at N9 with C8-N9-C10-C11 torsion angles of 93.0(2) and 50.8(6)/-97.0(6)degrees, respectively.